Approximately 95 percent of cancer mortality is caused by metastasis. This fact is what motivates many cancer researchers to focus on finding new ways to stop or kill the growth of metastatic cancer cells. A new paper published ...
Jul 6, 2016
0
44
Delaying surgery after a diagnosis of uterine cancer can increase a women's risk of death, but operating too soon can be just as detrimental for some, Penn Medicine physicians report in a new study published in the American ...
Dec 16, 2016
0
34
In the largest genomics study of clear cell endometrial cancer (CCEC) tumors to date, National Human Genome Research Institute (NHGRI) researchers and their collaborators have identified mutations in the TAF1 gene. They've ...
May 9, 2017
0
42
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from ...
Mar 20, 2022
0
94
A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...
Dec 22, 2014
0
0
New research published in Diabetologia shows that cancer mortality in people with type 2 diabetes is substantially higher than in the general population, by 18% for all cancers combined, 9% for breast cancer and 2.4 times ...
Jan 24, 2023
0
3
Endometrial cancer triggers remain elusive, despite continued research. But given the typical inflammatory profile in these cases, microbes in the uterine environment are suspected to play a role in the development of this ...
Jan 5, 2017
0
2
A comprehensive study from Uppsala University involving more than 250,000 women shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing ...
Dec 17, 2020
0
189
Women with obesity and endometrial cancer who lose weight in advance of surgery have fewer complications and shorter hospital stays, according to preliminary study results so promising that they are already changing the standard ...
Feb 15, 2022
0
0
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare ...
Apr 17, 2023
0
15
